Key result
CMR identified myocarditis in 90% of patients with autoimmune diseases and cardiac symptoms, showing higher T2-W signal ratios than asymptomatic controls (1.89 vs 1.57; P<0.05).
Why the study?
Can Cardiovascular Magnetic Resonance (CMR) reliably detect myocardial inflammation in patients with autoimmune diseases and cardiac symptoms?
Case-Control (n=40)
Can Cardiovascular Magnetic Resonance (CMR) reliably detect myocardial inflammation in patients with autoimmune diseases and cardiac symptoms?
Absolute Event Rate: 1.89% vs 1.57%
p-value: p=<0.05
Cardiovascular Magnetic Resonance is a reliable, noninvasive tool for detecting myocardial inflammation, which is a common finding in patients with autoimmune diseases presenting with cardiac symptoms.
CMR may aid myocarditis detection in symptomatic autoimmune patients; hypothesis-generating and requires prospective validation before practice change.
INTRODUCTION: Myocardial inflammation often coexists with different types of autoimmune diseases. Our aim was to investigate the presence of myocarditis in these patients by Cardiovascular Magnetic Resonance (CMR) and endomyocardial biopsy. PATIENTS-METHODS: Twenty patients, aged 20-55 yrs with autoimmune diseases and cardiac symptoms (3 with Takayasu's arteritis, 3 with systemic lupus erythematosus, 5 with rheumatoid arthritis, 7 with autoimmune thyroid disease and 2 with systemic sclerosis) and 20 patients with the same autoimmune diseases but without cardiac symptoms (controls) were studied. The presence of myocarditis and LV function were evaluated by CMR. Myocarditis was documented using T2-weighted (T2-W), T1-weighted (T1-W) before and after contrast media injection and late enhanced images. In 10 patients (positive for myocarditis by CMR with either low LVEF or recent increase in troponin), endomyocardial biopsy was also performed. Myocardial specimens were evaluated by histology and polymerase chain reaction techniques (PCR). RESULTS: Myocarditis was identified in 18/20 patients by CMR. In the T2-W images the signal ratio of myocardium to skeletal muscle was 1.89+/-0.25 (control values 1.57+/-0.13, p<0.05). From the T1-W images the relative myocardial enhancement was 11.31+/-11.18 (control values 3.09+/-0.05, p<0.05). Epicardial late gadolinium enhanced areas were identified in 18/20. In myocardial specimens, histology revealed inflammation in 5/10 (50%) and PCR documented viral or microbial genomes in 8/10 (80%). Positive histology and PCR were in agreement with 50% and 80% of positive CMR examinations, respectively. Herpes virus was identified in 3/10, Adeno in 1/10, Coxsackie B6 in 1/10, echo in 1/10, Parvo-B19 in 3/10, CMV in 1/10 and Chlamydia trachomatis in 8/10. CONCLUSIONS: Myocardial inflammation is a common finding in patients with autoimmune diseases and cardiac symptoms. The diagnosis can be confirmed by CMR, which is a noninvasive and reliable tool for the investigation of these patients.
No takes yet. Share an insight, caveat, or question.
Mavrogeni et al. (2009) conducted a case-control in Autoimmune diseases with cardiac symptoms (n=40). Cardiac symptoms vs. No cardiac symptoms was evaluated on T2-W signal ratio of myocardium to skeletal muscle (p=<0.05). CMR identified myocarditis in 90% of patients with autoimmune diseases and cardiac symptoms, showing higher T2-W signal ratios than asymptomatic controls (1.89 vs 1.57; P<0.05).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: